Lexpos News

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued guidance regarding the use of prolonged-release opioids in post-operative pain. The indication for the treatment of post-operative pain has been removed from the licences of all prolonged release opioids including prolonged-release morphine and prolonged-release oxycodone, due to the increased risk of persistent post-operative opioid use [...]

The post MHRA Drug Safety Update: Use of prolonged-release opioids in post-operative pain appeared first on Community Pharmacy England.

NHS England has published an invitation to tender (ITT) inviting community pharmacy owners interested in providing a Community Pharmacy Respiratory Syncytial Virus (RSV) and Pertussis Vaccination Enhanced Service. Announcement of the tender, follows on from the September 2024 introduction of the RSV vaccination programme in general practice and NHS trusts and the initial commissioning of [...]

The post Provision of RSV and Pertussis vacs from May 2025 appeared first on Community Pharmacy England.

Community Pharmacy England met with 50 MPs and parliamentary staff at the Houses of Parliament yesterday (Tuesday 11th March) to discuss the vital healthcare role that pharmacies play in local communities and how the critical pressures on community pharmacies are putting this at risk. During the busy Westminster event MPs were asked to support the call to protect [...]

The post Strong support for pharmacy at Parliamentary event appeared first on Community Pharmacy England.

This recall notification has been updated since its initial publication on 11 March 2025 to include the correct information in relation to the safety updates in the Patient Information Leaflet (PIL) and the changes that have been made in line with reference product PIL. MHRA Class 4 Medicines Notification: Azithromycin 250 mg Capsules (Jubilant Pharmaceuticals [...]

The post Update – MHRA Class 4 Medicines Defect Notification: Azithromycin 250 mg Capsules (Jubilant Pharmaceuticals NV) appeared first on Community Pharmacy England.

Multi-Factor Authentication (MFA) is becoming mandatory for all NHSmail users. The NHSmail team previously announced that users would be prompted to enable MFA from late 2024, and a rollout timeline was introduced to support this transition. This initiative follows earlier announcements (from 2023 onwards) about NHSmail MFA becoming a mandatory requirement. What is MFA? Previously, you [...]

The post Reminder: Mandatory NHSmail Multi-Factor Authentication for all users appeared first on Community Pharmacy England.